Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an αvβ3 integrin-targeted fluorochrome

Journal of Nuclear Medicine

Volumn 49, Issue 11, 2008, Pages 1845-1851

  Waldeck, Jens ^a   Häger, Florian ^a   Höltke, Carsten ^a   Lanckohr, Christian ^a   Von Wallbrunn, Angelika ^a   Torsello, Giovanni ^b   Heindel, Walter ^a   Theilmeier, Gregor ^c   Schäfers, Michael ^a   Bremer, Christoph ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b ST FRANZISKUS HOSPITAL   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

v 3 integrin; Atherosclerotic plaque; Fluorescence reflectance imaging; Optical imaging; RGD Cy 5.5

Indexed keywords

APOLIPOPROTEIN E; ARGINYLGLYCYLASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID CYANINE 5 5 CONJUGATE; CYANINE DYE 5; FLUOROCHROME; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BINDING AFFINITY; CAROTID ARTERY; CONTROLLED STUDY; EXPERIMENTAL MODEL; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MOLECULAR PROBE; MOUSE; NEAR INFRARED REFLECTANCE SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CARBOCYANINES; CELL LINE; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENT DYES; HUMANS; INFRARED RAYS; INTEGRIN ALPHAVBETA3; MACROPHAGES; MICE; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; PEPTIDES, CYCLIC; PROTEIN BINDING; SUBSTRATE SPECIFICITY;

EID: 57349131867     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.052514     Document Type: Article

References (40)

1. Theilmeier G, Quarck R, Verhamme P, et al. Hypercholesterolemia impairs vascular remodelling after porcine coronary angioplasty. Cardiovasc Res. 2002;55:385-395.
2. Martinet W, De Meyer GR. Selective depletion of macrophages in atherosclerotic plaques: myth, hype, or reality? Circ Res. 2007;100:751-753.
3. Schafers M, Riemann B, Kopka K, et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation. 2004;109:2554-2559.
4. Libby P, Ridker PM. Inflammation and artherothrombosis: from population biology and bench research to clinical practice. J Am Coll Cardiol. 2006;48(suppl A):A33-A46.
5. MacNeill BD, Jang IK, Bouma BE, et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol. 2004;44:972-979.
6. Lessner SM, Prado HL, Waller EK, Galis ZS. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am J Pathol. 2002;160:2145-2155.
7. Swirski FK, Libby P, Aikawa E, et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest. 2007;117:195-205.
8. Swirski FK, Pittet MJ, Kircher MF, et al. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci USA. 2006;103:10340-10345.
9. Antonov AS, Kolodgie FD, Munn DH, Gerrity RG. Regulation of macrophage foam cell formation by aVb3 integrin: potential role in human atherosclerosis. Am J Pathol. 2004;165:247-258.
10. Meyer A, Auernheimer J, Modlinger A, Kessler H. Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting. Curr Pharm Des. 2006;12:2723-2747.
11. 3 as a target in the prevention of neointimal hyperplasia. J Vasc Surg. 2007;45(suppl):A33-A38.
12. Cheresh DA, Spiro RC. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem. 1987;262:17703-17711.
13. D'Souza SE, Ginsberg MH, Matsueda GR, Plow EF. A discrete sequence in a platelet integrin is involved in ligand recognition. Nature. 1991;350:66-68.
14. Brooks PC, Stromblad S, Sanders LC, et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin av β3. Cell. 1996;85:683-693.
15. van Hinsbergh VW, Engelse MA, Quax PH. Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol. 2006;26:716-728.
16. 3 expression using fluorescence-mediated tomography. Eur J Nucl Med Mol Imaging. November 28, 2006 [Epub ahead of print].
17. Ivan E, Khatri JJ, Johnson C, et al. Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions. Circulation. 2002;105:2686-2691.
18. Chung A, Gao Q, Kao WJ. Macrophage matrix metalloproteinase-2/-9 gene and protein expression following adhesion to ECM-derived multifunctional matrices via integrin complexation. Biomaterials. 2007;28:285-298.
19. Jaffer FA, Sosnovik DE, Nahrendorf M, Weissleder R. Molecular imaging of myocardial infarction. J Mol Cell Cardiol. 2006;41:921-933.
20. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science. 1987;238:491-497.
21. Chen X, Conti PS, Moats RA. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res. 2004;64:8009-8014.
22. Schraa AJ, Kok RJ, Moorlag HE, et al. Targeting of RGD-modified proteins to tumor vasculature: a pharmacokinetic and cellular distribution study. Int J Cancer. 2002;102:469-475.
23. D'Souza SE, Ginsberg MH, Plow EF. Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif. Trends Biochem Sci. 1991;16:246-250.
24. Pfaff M, Tangemann K, Muller B, et al. Selective recognition of cyclic RGD peptides of NMR defined conformation by αIIbβ3, αVβ3, and α5β1 integrins. J Biol Chem. 1994;269:20233-20238.
25. Yamada KM. Adhesive recognition sequences. J Biol Chem. 1991;266:12809-12812.
26. Pierschbacher MD, Ruoslahti E. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem. 1987;262:17294-17298.
27. 3 integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med. 1999;40:1061-1071.
28. 3 integrin binding peptides in a nude mouse model. Cancer Res. 2002;62:6146-6151.
29. Colombo G, Curnis F, De Mori GM, et al. Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif. J Biol Chem. 2002;277:47891-47897.
30. Yamada T, Uyeda A, Kidera A, Kikuchi M. Functional analysis and modeling of a conformationally constrained Arg-Gly-Asp sequence inserted into human lysozyme. Biochemistry. 1994;33:11678-11683.
31. 3 expression. Nuklearmedizin. 2004;43:26-32.
32. Haubner R, Wester HJ, Burkhart F, et al. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med. 2001;42:326-336.
33. Xu Q. Mouse models of arteriosclerosis: from arterial injuries to vascular grafts. Am J Pathol. 2004;165:1-10.
34. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood. 1993;81:1607-1613.
35. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 1994;264:569-571.
36. Meoli DF, Sadeghi MM, Krassilnikova S, et al. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest. 2004;113:1684-1691.
37. Persigehl T, Heindel W, Bremer C. MR and optical approaches to molecular imaging. Abdom Imaging. 2005;30:342-354.
38. Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007;50:933-939.
39. Upadhyay R, Sheth RA, Weissleder R, Mahmood U. Quantitative real-time catheter-based fluorescence molecular imaging in mice. Radiology. 2007;245:523-531.
40. Ntziachristos V, Tung CH, Bremer C, Weissleder R. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med. 2002;8:757-760.